Literature DB >> 11469986

Postinfectious Irritable Bowel Syndrome.

Kok-Ann Gwee1.   

Abstract

Postinfectious irritable bowel syndrome (PI-IBS) should be considered in patients who present with a change in bowel habits or an onset of new abdominal pain or discomfort following a recent confirmed or presumed exposure to infectious organisms, or in those who have recently returned from a tropical or developing country. In patients who are greatly distressed by their symptoms, an extended workup early in the course of their illness may give physician and patient confidence in focusing on IBS. The author favors a proactive, multicomponent approach to management, as it gives the physician and patient a sense of control. Treatment should include stress management, dietary advice to minimize exposure to trigger foods, and pharmacotherapy to alleviate anxiety and target disturbed physiology.

Entities:  

Year:  2001        PMID: 11469986     DOI: 10.1007/s11938-001-0053-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  36 in total

Review 1.  The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

Authors:  D A Drossman; W G Thompson
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

2.  Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved.

Authors:  M Gué; C Bonbonne; J Fioramonti; J Moré; C Del Rio-Lachèze; C Coméra; L Buéno
Journal:  Am J Physiol       Date:  1997-01

3.  Ischemic colitis during treatment with alosetron.

Authors:  D Friedel; R Thomas; R S Fisher
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

4.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.

Authors:  G Pan; S Lu; M Ke; S Han; H Guo; X Fang
Journal:  Chin Med J (Engl)       Date:  2000-01       Impact factor: 2.628

6.  Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome.

Authors:  R Hussain; W Jaferi; S Zuberi; R Baqai; N Abrar; A Ahmed; V Zaman
Journal:  Am J Trop Med Hyg       Date:  1997-03       Impact factor: 2.345

7.  Effect of changing transit time on colonic microbial metabolism in man.

Authors:  A M Stephen; H S Wiggins; J H Cummings
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

8.  The irritable bowel syndrome: long-term prognosis and the physician-patient interaction.

Authors:  D M Owens; D K Nelson; N J Talley
Journal:  Ann Intern Med       Date:  1995-01-15       Impact factor: 25.391

9.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

10.  Abnormal colonic fermentation in irritable bowel syndrome.

Authors:  T S King; M Elia; J O Hunter
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

View more
  4 in total

1.  Cryptosporidium parvum isolate-dependent postinfectious jejunal hypersensitivity and mast cell accumulation in an immunocompetent rat model.

Authors:  Samira Khaldi; Gilles Gargala; Laetitia Le Goff; Simon Parey; Arnaud Francois; Jean Fioramonti; Jean-Jacques Ballet; Jean-Paul Dupont; Philippe Ducrotté; Loïc Favennec
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

2.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Authors:  Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad
Journal:  BMC Gastroenterol       Date:  2010-11-12       Impact factor: 3.067

3.  Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects.

Authors:  Teemu Rinttilä; Anna Lyra; Lotta Krogius-Kurikka; Airi Palva
Journal:  Gut Pathog       Date:  2011-04-26       Impact factor: 4.181

Review 4.  Mechanisms and management of functional abdominal pain.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  J R Soc Med       Date:  2014-09       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.